These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7575349)

  • 1. Monomeric and dimeric forms of soluble receptors can differ in their neutralization potential.
    Lauffer L; Kanzy EJ; Köhler R; Kurrle R; Enssle K; Seiler FR
    Behring Inst Mitt; 1995 Jun; (96):21-31. PubMed ID: 7575349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of natural and recombinant soluble interleukin-4 receptor.
    Enssle K; Enders B; Kurrle R; Lauffer L; Schorlemmer HU; Dickneite G; Kanzy EJ; Seiler FR
    Behring Inst Mitt; 1995 Jun; (96):103-17. PubMed ID: 7575346
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of IL-1 activity by soluble IL-1 receptors.
    Kurrle R; Lauffer L; Röder J; Kanzy EJ; Enssle KH; Seiler FR
    Behring Inst Mitt; 1995 Jun; (96):45-57. PubMed ID: 7575352
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of a soluble, high affinity human interleukin 4 binding protein in normal human urine.
    Christie G; Dacey I; Weston BJ
    Cytokine; 1995 May; 7(4):305-10. PubMed ID: 8589259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
    Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
    J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic mutant proteins of interleukin-4.
    Duschl A; Müller T; Sebald W
    Behring Inst Mitt; 1995 Jun; (96):87-94. PubMed ID: 7575356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes.
    Jerva LF; Sullivan G; Lolis E
    Protein Sci; 1997 Aug; 6(8):1643-52. PubMed ID: 9260277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
    Pullen SS; Labadia ME; Ingraham RH; McWhirter SM; Everdeen DS; Alber T; Crute JJ; Kehry MR
    Biochemistry; 1999 Aug; 38(31):10168-77. PubMed ID: 10433725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.
    Schreuder H; Tardif C; Trump-Kallmeyer S; Soffientini A; Sarubbi E; Akeson A; Bowlin T; Yanofsky S; Barrett RW
    Nature; 1997 Mar; 386(6621):194-200. PubMed ID: 9062194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The search for inhibitors of interleukin-1 based on the sequence of interleukin-1 receptor antagonist.
    Wieczorek Z; Kluczyk A; Slon-Usakiewicz JJ; Siemion IZ
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(4):123-9. PubMed ID: 9575352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The production of soluble interleukin 4 receptors is preferentially regulated by the murine Th2 cell subset.
    Fernandez-Botran R; Chilton PM; Ma Y; Windsor JL; Street NE
    Cytokine; 1997 Mar; 9(3):166-77. PubMed ID: 9126705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
    Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model of the complex between interleukin-4 and its receptors.
    Gustchina A; Zdanov A; Schalk-Hihi C; Wlodawer A
    Proteins; 1995 Feb; 21(2):140-8. PubMed ID: 7777489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the domain in the human interleukin-11 receptor that mediates ligand binding.
    Schleinkofer K; Dingley A; Tacken I; Federwisch M; Müller-Newen G; Heinrich PC; Vusio P; Jacques Y; Grötzinger J
    J Mol Biol; 2001 Feb; 306(2):263-74. PubMed ID: 11237599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of the tumor necrosis factor receptor superfamily.
    Bajorath J
    J Mol Graph Model; 1999; 17(3-4):220-2. PubMed ID: 10736780
    [No Abstract]   [Full Text] [Related]  

  • 17. Relative cytokine and cytokine inhibitor production by mononuclear cells and neutrophils.
    Xing L; Remick DG
    Shock; 2003 Jul; 20(1):10-6. PubMed ID: 12813362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion.
    Fischer M; Goldschmitt J; Peschel C; Brakenhoff JP; Kallen KJ; Wollmer A; Grötzinger J; Rose-John S
    Nat Biotechnol; 1997 Feb; 15(2):142-5. PubMed ID: 9035138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global and local determinants for the kinetics of interleukin-4/interleukin-4 receptor alpha chain interaction. A biosensor study employing recombinant interleukin-4-binding protein.
    Shen BJ; Hage T; Sebald W
    Eur J Biochem; 1996 Aug; 240(1):252-61. PubMed ID: 8797861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of the extracellular binding regions of the human interleukin-8 type B receptor.
    Katancik JA; Sharma A; Radel SJ; De Nardin E
    Biochem Biophys Res Commun; 1997 Mar; 232(3):663-8. PubMed ID: 9126332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.